Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia

por Latuske, Emily-Marie, Stamm, Hauke, Klokow, Marianne, Vohwinkel, Gabi, Muschhammer, Jana, Bokemeyer, Carsten, Jücker, Manfred, Kebenko, Maxim, Fiedler, Walter, Wellbrock, Jasmin
Publicado 2017

Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma

por Brauneck, Franziska, Weimer, Pauline, Schulze zur Wiesch, Julian, Weisel, Katja, Leypoldt, Lisa, Vohwinkel, Gabi, Fritzsche, Britta, Bokemeyer, Carsten, Wellbrock, Jasmin, Fiedler, Walter
Publicado 2021

Overexpression of Gremlin-1 in Patients with Loeys-Dietz Syndrome: Implications on Pathophysiology and Early Disease Detection

por Wellbrock, Jasmin, Sheikhzadeh, Sara, Oliveira-Ferrer, Leticia, Stamm, Hauke, Hillebrand, Mathias, Keyser, Britta, Klokow, Marianne, Vohwinkel, Gabi, Bonk, Veronika, Otto, Benjamin, Streichert, Thomas, Balabanov, Stefan, Hagel, Christian, Rybczynski, Meike, Bentzien, Frank, Bokemeyer, Carsten, von Kodolitsch, Yskert, Fiedler, Walter
Publicado 2014

Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

por Stamm, Hauke, Klingler, Felix, Grossjohann, Eva-Maria, Muschhammer, Jana, Vettorazzi, Eik, Heuser, Michael, Mock, Ulrike, Thol, Felicitas, Vohwinkel, Gabi, Latuske, Emily, Bokemeyer, Carsten, Kischel, Roman, Dos Santos, Cedric, Stienen, Sabine, Friedrich, Matthias, Lutteropp, Michael, Nagorsen, Dirk, Wellbrock, Jasmin, Fiedler, Walter
Publicado 2018